Advertisement
Screener

Aditxt, Inc. (ADTX) Deferred Tax Assets, Valuation Allowance

2.8 / 5 stars · 68/120 Roast Me

Aditxt, Inc. Deferred Tax Assets, Valuation Allowance

Aditxt, Inc. (ADTX) had Deferred Tax Assets, Valuation Allowance of $44.46 million as of 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-03-31

  • 2025-12-31: Deferred Tax Assets, Valuation Allowance $44.46M.
  • 2024-12-31: Deferred Tax Assets, Valuation Allowance $34.56M; Deferred Tax Assets, Valuation Allowance as first filed $34.56M.
  • 2023-12-31: Deferred Tax Assets, Valuation Allowance $26.41M.
  • 2022-12-31: Deferred Tax Assets, Valuation Allowance $20.22M; Deferred Tax Assets, Valuation Allowance as first filed $3.50M.
Period endDeferred Tax Assets, Valuation AllowanceDeferred Tax Assets, Valuation Allowance as first filed
2025-12-31$44.46M
10-K · filed 2026-03-31
2024-12-31$34.56M
10-K · filed 2026-03-31
$34.56M
10-K · filed 2025-03-31
2023-12-31$26.41M
10-K · filed 2025-03-31
2022-12-31$20.22M
10-K · filed 2024-04-16
$3.50M
10-K · filed 2023-04-17
2021-12-31$10.60M
10-K · filed 2022-03-31
2020-12-31$6.11M
10-K · filed 2021-03-25
2019-12-31$2.02M
10-K · filed 2021-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rafael Holdings, Inc. (RFL)United States$0.000B-0.00
CDT Equity Inc. (CDT)United States$0.000B-0.01
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B